Bafna Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

152.47

115.35

85.14

71.22

42.47

Operating profit

11.11

15.72

11.49

10.30

1.23

Interest

2.29

2.04

0.79

0.74

0.10

Gross profit

12.34

16.95

12.80

10.31

1.39

EPS (Rs)

3.11

4.79

2.18

2.46

-106.54

Other income

3.52

3.27

2.10

0.75

0.26

Stock adjustment

-4.85

-2.91

-1.77

2.95

-3.24

Raw material

79.01

59.57

53.06

42.51

30.24

Power and fuel

-

-

-

-

-

Employee expenses

19.03

15.87

14.50

11.98

10.25

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

48.17

27.11

7.86

3.48

3.99

Provisions made

-

-

-

-

-

Depreciation

5.00

5.33

5.49

4.48

3.27

Taxation

-

0.28

-

-

-

Net profit / loss

7.35

11.34

5.15

5.83

-25.20

Extra ordinary item

-

-

-2.16

-

-23.33

Prior year adjustments

-

-

-

-

-

Equity capital

23.66

23.66

23.66

23.66

2.37

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

7.29

13.62

13.50

14.46

2.89

GPM (%)

7.91

14.29

14.67

14.32

3.25

NPM (%)

4.71

9.56

5.90

8.10

-58.99